| References |
1. Qian T, Wo J, Zhang Y, Song Q, Feng G, Luo R, Lin S, Wu G, Chen HF. Crystal Structure of StnA for the Biosynthesis of Antitumor Drug Streptonigrin Reveals a Unique Substrate Binding Mode. Sci Rep. 2017 Jan 11;7:40254. doi: 10.1038/srep40254. PubMed PMID: 28074848; PubMed Central PMCID: PMC5225493. 2. Kong D, Zou Y, Zhang Z, Xu F, Brock NL, Zhang L, Deng Z, Lin S. Identification of (2S,3S)-β-Methyltryptophan as the Real Biosynthetic Intermediate of Antitumor Agent Streptonigrin. Sci Rep. 2016 Feb 5;6:20273. doi: 10.1038/srep20273. PubMed PMID: 26847951; PubMed Central PMCID: PMC4742848. 3. Xia X, Lin S, Xia XX, Cong FS, Zhong JJ. Significance of agitation-induced shear stress on mycelium morphology and lavendamycin production by engineered Streptomyces flocculus. Appl Microbiol Biotechnol. 2014 May;98(10):4399-407. doi: 10.1007/s00253-014-5555-4. Epub 2014 Feb 13. PubMed PMID: 24522728. 4. Xu F, Kong D, He X, Zhang Z, Han M, Xie X, Wang P, Cheng H, Tao M, Zhang L, Deng Z, Lin S. Characterization of streptonigrin biosynthesis reveals a cryptic carboxyl methylation and an unusual oxidative cleavage of a N-C bond. J Am Chem Soc. 2013 Feb 6;135(5):1739-48. doi: 10.1021/ja3069243. Epub 2013 Jan 22. PubMed PMID: 23301954. |
